Financials
- Market Capitalization 11.69 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-37.39
市销率
16.85
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 800 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.38 USD | +0.03% | -7.50% | -0.68% | +54.53% | 12.26 B USD | ||
| 803 | HALO Halozyme Therapeutics, Inc. - Common Stock | 107.72 USD | +1.16% | -1.46% | +30.41% | +61.26% | 12.23 B USD | ||
| 841 | TECH Bio-Techne Corp - Common Stock | 72.18 USD | -0.18% | -0.21% | +0.06% | +34.66% | 11.32 B USD | ||
| 843 | SMMT Summit Therapeutics Inc. - Common Stock | 14.16 USD | +3.96% | -4.00% | +9.34% | -28.70% | 11.30 B USD |